SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-010520
Filing Date
2021-05-05
Accepted
2021-05-05 16:05:44
Documents
20
Period of Report
2021-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 64907
2 ex3-1.htm EX-3.1 49832
3 ex5-1.htm EX-5.1 13764
4 ex10-1.htm EX-10.1 72709
5 ex99-1.htm EX-99.1 9829
6 ex99-2.htm EX-99.2 15318
7 ex99-3.htm EX-99.3 52693
8 ex99-1_001.jpg GRAPHIC 4678
9 image_001.jpg GRAPHIC 4681
  Complete submission text file 0001493152-21-010520.txt   521188

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE hrow-20210505.xsd EX-101.SCH 3026
11 XBRL LABEL FILE hrow-20210505_lab.xml EX-101.LAB 34914
12 XBRL PRESENTATION FILE hrow-20210505_pre.xml EX-101.PRE 22789
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3883
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21893200
SIC: 2834 Pharmaceutical Preparations